Combination treatment of Cetuximab and Wnt inhibitor mitigated tumor growth in CHD6-high human patient-derived xenograft (PDX) CRC model with better efficacy through hindering CHD6-TMEM65 signaling axis. The gene discussed is CHD6; the disease is colorectal carcinoma.